New drug combo aims to tackle tough lymphoma cases
NCT ID NCT07197307
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests whether combining two drugs, loncastuximab tesirine and epcoritamab, can safely and effectively treat people with aggressive B-cell lymphoma that has come back or not responded to prior therapy. The trial will include 120 adults who have either not had CAR-T cell therapy or whose lymphoma progressed after CAR-T cells. The main goal is to see how many patients achieve a complete or partial remission within 12 months of starting treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charite Universitaetsmedizin Berlin
RECRUITINGBerlin, 12203, Germany
-
Diakonie-Klinikum Stuttgart Diakonissenkrankenhaus und Paulinenhilfe
NOT_YET_RECRUITINGStuttgart, 70176, Germany
-
Evangelisches Klinikum Bethel
RECRUITINGBielefeld, 33611, Germany
-
HELIOS Klinikum Berlin-Buch
RECRUITINGBerlin, 13125, Germany
-
Kliniken Ostalb gemeinnuetzige kommunale Anstalt des oeffentlichen Rechts
RECRUITINGMutlangen, 73557, Germany
-
Klinikum Chemnitz
RECRUITINGChemnitz, 09116, Germany
-
Klinikum Oldenburg
RECRUITINGOldenburg, 26133, Germany
-
Klinikum der Universitaet Muenchen
NOT_YET_RECRUITINGMünchen, 81377, Germany
-
Medical Center - University Of Freiburg
RECRUITINGFreiburg im Breisgau, 79106, Germany
-
Medizinisches Versorgungszentrum des Bruederkrankenhauses St. Josef Paderborn
RECRUITINGPaderborn, 33098, Germany
-
Muehlenkreiskliniken
RECRUITINGMinden, 32429, Germany
-
Ortenau Klinikum
RECRUITINGOffenburg, 77654, Germany
-
Philipps-Universitaet Marburg
RECRUITINGMarburg, 35043, Germany
-
St. Barbara-Klinik Hamm
RECRUITINGHamm, 59073, Germany
-
Staedtisches Klinikum Karlsruhe
RECRUITINGKarlsruhe, 76133, Germany
-
Universitaet Des Saarlandes
RECRUITINGHomburg, 66421, Germany
-
Universitaetsklinikum Aachen
RECRUITINGAachen, 52074, Germany
-
Universitaetsklinikum Augsburg
RECRUITINGAugsburg, 86156, Germany
-
Universitaetsklinikum Duesseldorf
RECRUITINGDüsseldorf, 40225, Germany
-
Universitaetsklinikum Erlangen
RECRUITINGErlangen, 91054, Germany
-
Universitaetsklinikum Essen
NOT_YET_RECRUITINGEssen, 45147, Germany
-
Universitaetsklinikum Frankfurt
RECRUITINGFrankfurt, 60590, Germany
-
Universitaetsklinikum Halle (Saale)
RECRUITINGHalle, 06120, Germany
-
Universitaetsklinikum Heidelberg
RECRUITINGHeidelberg, 69120, Germany
-
Universitaetsklinikum Jena
RECRUITINGJena, 07747, Germany
-
Universitaetsklinikum Regensburg
RECRUITINGRegensburg, 93053, Germany
-
Universitaetsklinikum Schleswig-Holstein
RECRUITINGKiel, 24105, Germany
-
Universitaetsklinikum Schleswig-Holstein
RECRUITINGLübeck, 23538, Germany
-
Universitaetsklinikum Ulm
RECRUITINGUlm, 89081, Germany
-
Universitaetsmedizin Greifswald
RECRUITINGGreifswald, 17489, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
RECRUITINGMainz, 55131, Germany
-
University Medical Center Hamburg-Eppendorf
NOT_YET_RECRUITINGHamburg, 20246, Germany
-
Universitätsklinikum Münster, Medizinische Klinik A
RECRUITINGMünster, 48149, Germany
-
Vivantes Netzwerk fuer Gesundheit
RECRUITINGBerlin, 10967, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for HIV patients with aggressive lymphoma: early trial launches
- Engineered immune cells take on tough lymphoma
- CAR t therapy aims to snuff out hidden lymphoma cells
- New hope for hard-to-treat lymphoma: three-drug combo enters early trials
- Withdrawn trial: could glofitamab stop hidden lymphoma cells?
- New pill plus chemo aims to beat High-Risk lymphoma